Company intelligence / Profile preview
Invion Limited
South Melbourne, Victoria, Australiainviongroup.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Invion has demonstrated promising preclinical and early clinical results with its Photosoft™ photodynamic therapy platform. The lead compound INV043 has shown tumor regression in multiple models and improved outcomes when combined with immune checkpoint inhibitors. Clinical trials include a completed Phase II study in prostate cancer and ongoing or planned trials for non-melanoma skin cancers and anogenital cancers. The technology also shows potential against infectious diseases like COVID‑19 variants.
- Therapeutic areas
- OncologyCardiovascularInfectious Diseases
- Modalities
- Photodynamic Therapy (PDT)Small molecules (photosensitizers)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Hanlim Pharm Co., Ltd. — funding programs for glioblastoma multiforme & esophageal cancer without requiring capital/IP from InvionDr.inB — funding HPV-related program(s) without capital/IP from InvionPeter MacCallum Cancer Centre — research collaborationHudson Institute of Medical Research — research collaborationViroclinics — infectious disease studiesAustralian Centre for Antimicrobial Resistance Ecology at University of Adelaide — antimicrobial studies
Beyond the preview
Go deeper on Invion Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Invion Limited.